• 2020
  Quereda JJ, Morel C, Lopez-Montero N, Ziveri J, Rolland S, Grenier T, Aulner N, Danckaert A, Charbit A, Enninga J, Cossart P, Pizarro-Cerdá J, , A role for Taok2 in Listeria monocytogenes vacuolar escape., J. Infect. Dis. 2020 Jun; (): .
• 2020
  Lecoeur H, Prina E, Rosazza T, Kokou K, N'Diaye P, Aulner N, Varet H, Bussotti G, Xing Y, Milon G, Weil R, Meng G, Späth GF, , Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory Response., Cell Rep 2020 Feb; 30(6): 1870-1882.e4.
• 2019
  Lamotte S, Aulner N, Späth GF, Prina E, , Author Correction: Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening., Sci Rep 2019 Jul; 9(1): 10148.
• 2019
  Aulner N, Danckaert A, Ihm J, Shum D, Shorte SL, Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases, Trends Parasitol. 2019 Jul;35(7):559-570.
• 2019
  Lamotte S, Aulner N, Späth GF, Prina E, Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening, Sci Rep 2019 Jan;9(1):438.
• 2018
  Aulner N, Danckaert A, Fernandes J, Nicola MA, Roux P, Salles A, Tinevez JY, Shorte SL, Fluorescence imaging host pathogen interactions: fifteen years benefit of hindsight…, Curr. Opin. Microbiol. 2018 06;43:193-198.
• 2017
  Quereda JJ, Sachse M, Balestrino D, Grenier T, Fredlund J, Danckaert A, Aulner N, Shorte S, Enninga J, Cossart P, Pizarro-Cerdá J, Assessing Vacuolar Escape of Listeria Monocytogenes, Methods Mol. Biol. 2017;1535:173-195.
• 2016
  Horvath P, Aulner N, Bickle M, Davies AM, Nery ED, Ebner D, Montoya MC, Östling P, Pietiäinen V, Price LS, Shorte SL, Turcatti G, von Schantz C, Carragher NO, Screening out irrelevant cell-based models of disease, Nat Rev Drug Discov 2016 11;15(11):751-769.
• 2016
  Durieu E, Prina E, Leclercq O, Oumata N, Gaboriaud-Kolar N, Vougogiannopoulou K, Aulner N, Defontaine A, No JH, Ruchaud S, Skaltsounis AL, Galons H, Späth GF, Meijer L, Rachidi N, From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity, Antimicrob. Agents Chemother. 2016 05;60(5):2822-33.
• 2015
  Quereda JJ, Pizarro-Cerdá J, Balestrino D, Bobard A, Danckaert A, Aulner N, Shorte S, Enninga J, Cossart P, A Dual Microscopy-Based Assay To Assess Listeria monocytogenes Cellular Entry and Vacuolar Escape, Appl. Environ. Microbiol. 2016 01;82(1):211-7.
• 2014
  Mellouk N, Weiner A, Aulner N, Schmitt C, Elbaum M, Shorte SL, Danckaert A, Enninga J, Shigella subverts the host recycling compartment to rupture its vacuole, Cell Host Microbe 2014 Oct;16(4):517-30.
• 2013
  Rachidi N, Taly JF, Durieu E, Leclercq O, Aulner N, Prina E, Pescher P, Notredame C, Meijer L, Späth GF, Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection, Antimicrob. Agents Chemother. 2014;58(3):1501-15.
• 2013
  Ortica S, Tarantino N, Aulner N, Israël A, Gupta-Rossi N, The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors, FASEB J. 2014 Feb;28(2):603-14.
• 2013
  Aulner N, Danckaert A, Rouault-Hardoin E, Desrivot J, Helynck O, Commere PH, Munier-Lehmann H, Späth GF, Shorte SL, Milon G, Prina E, High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery, PLoS Negl Trop Dis 2013;7(4):e2154.
• 2009
  Nobile C, Rudnicka D, Hasan M, Aulner N, Porrot F, Machu C, Renaud O, Prévost MC, Hivroz C, Schwartz O, Sol-Foulon N, HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes, J. Virol. 2010 Mar;84(5):2282-93.
• 2009
  Paumet F, Wesolowski J, Garcia-Diaz A, Delevoye C, Aulner N, Shuman HA, Subtil A, Rothman JE, Intracellular bacteria encode inhibitory SNARE-like proteins, PLoS ONE 2009 Oct;4(10):e7375.
• 2009
  Rinderspacher A, Cremona ML, Liu Y, Deng SX, Xie Y, Gong G, Aulner N, Többen U, Myers K, Chung C, Andersen M, Vidović D, Schürer S, Brandén L, Yamamoto A, Landry DW, Potent inhibitors of Huntingtin protein aggregation in a cell-based assay, Bioorg. Med. Chem. Lett. 2009 Mar;19(6):1715-7.
• 2009
  Wyler MR, Smith DH, Cayanis E, Többen U, Aulner N, Mayer T, Cell-based assays to probe the ERK MAP kinase pathway in endothelial cells, Methods Mol. Biol. 2009;486:29-41.
• 2008
  Gong G, Xie Y, Liu Y, Rinderspacher A, Deng SX, Feng Y, Zhu Z, Tang Y, Wyler M, Aulner N, Toebben U, Smith DH, Branden L, Chung C, Schürer S, Vidović D, Landry DW, Discovery of novel small molecule cell type-specific enhancers of NF-kappaB nuclear translocation, Bioorg. Med. Chem. Lett. 2009 Feb;19(4):1191-4.
• 2007
  Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS, Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation, Bioorg. Med. Chem. Lett. 2008 Jan;18(1):329-35.
• 2006
  Mayer T, Jagla B, Wyler MR, Kelly PD, Aulner N, Beard M, Barger G, Többen U, Smith DH, Brandén L, Rothman JE, Cell-based assays using primary endothelial cells to study multiple steps in inflammation, Meth. Enzymol. 2006;414:266-83.
• 2005
  Jagla B, Aulner N, Kelly PD, Song D, Volchuk A, Zatorski A, Shum D, Mayer T, De Angelis DA, Ouerfelli O, Rutishauser U, Rothman JE, Sequence characteristics of functional siRNAs, RNA 2005 Jun;11(6):864-72.
• 2005
  González-Zorn B, Senna JP, Fiette L, Shorte S, Testard A, Chignard M, Courvalin P, Grillot-Courvalin C, Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice, Infect. Immun. 2005 Mar;73(3):1847-51.
• 2004
  Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA, CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes, J. Immunol. 2004 Dec;173(12):7150-60.
• 2004
  Rollins RA, Korom M, Aulner N, Martens A, Dorsett D, Drosophila nipped-B protein supports sister chromatid cohesion and opposes the stromalin/Scc3 cohesion factor to facilitate long-range activation of the cut gene, Mol. Cell. Biol. 2004 Apr;24(8):3100-11.
• 2002
  Boëda B, El-Amraoui A, Bahloul A, Goodyear R, Daviet L, Blanchard S, Perfettini I, Fath KR, Shorte S, Reiners J, Houdusse A, Legrain P, Wolfrum U, Richardson G, Petit C, Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle, EMBO J. 2002 Dec;21(24):6689-99.
• 2002
  Monod C, Aulner N, Cuvier O, Käs E, Modification of position-effect variegation by competition for binding to Drosophila satellites, EMBO Rep. 2002 Aug;3(8):747-52.
• 2002
  Aulner N, Monod C, Mandicourt G, Jullien D, Cuvier O, Sall A, Janssen S, Laemmli UK, Käs E, The AT-hook protein D1 is essential for Drosophila melanogaster development and is implicated in position-effect variegation, Mol. Cell. Biol. 2002 Feb;22(4):1218-32.
• 2000
  Beaujean N, Bouniol-Baly C, Monod C, Kissa K, Jullien D, Aulner N, Amirand C, Debey P, Käs E, Induction of early transcription in one-cell mouse embryos by microinjection of the nonhistone chromosomal protein HMG-I, Dev. Biol. 2000 May;221(2):337-54.
• 1999
  Benoit B, Nemeth A, Aulner N, Kühn U, Simonelig M, Wahle E, Bourbon HM, The Drosophila poly(A)-binding protein II is ubiquitous throughout Drosophila development and has the same function in mRNA polyadenylation as its bovine homolog in vitro, Nucleic Acids Res. 1999 Oct;27(19):3771-8.